AirCurve 11 ASV
Adaptive-Servo Ventilation therapy
AirCurve™ 11 ASV* includes a widely clinically studied adaptive-servo ventilation therapy on the market for patients presenting with central sleep apnea (CSA), obstructive sleep apnea (OSA), mixed apneas and periodic breathing. The ASV* algorithm is designed to use each patient’s unique minute ventilation and respiratory rate to deliver therapy that stabilizes ventilation for more comfortable breathing throughout the night.
* ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnea.
Personalized support and powerful insights for improved support
AirCurve 11 comfort and support features are designed to encourage adherence to therapy by creating a more natural and helpful bilevel therapy experience. Designed to help drive positive outcomes, AirCurve 11 empowers providers to act on therapy insights, stay connected with patients and improve support for bilevel care.
Research indicates patients with complex sleep apnea attained an almost 90% reduction of apnea hypopnea index (AHI) when treated with ASV vs. a 65% AHI reduction when treated with CPAP.1
Enhanced Air11 ecosystem features
As part of the Air11™ series, AirCurve 11 includes the Resmed myAir™† online support program and app, Care Check-In and Personal Therapy Assistant, digital health solutions designed to help patients start and adhere to therapy. Care Check-In and Personal Therapy Assistant offer patients guided setup, troubleshooting support and tailored coaching. It’s like having a personal coach at their fingertips.‡
In a Resmed survey, a majority of patients stated they felt confident they could use Personal Therapy Assistant with Air11 and that it would help them resolve future Air11 PAP device issues on their own, giving providers the peace of mind knowing they’re helping give them the tools to succeed.2
Key features
- AirView™
Using AirView, providers can stay connected to patients, view invaluable insights and reports, manage patient records and troubleshoot remotely. - myAir™
Through myAir, patients have access to Care Check-In and Personal Therapy Assistant to help them get started and stay on therapy. - ASVAuto mode
Auto-adjusts EPAP to maintain upper airway patency and learns, predicts, responds to and optimizes pressures to suit each patient’s own unique breathing pattern.
- Easy-Breathe waveform
Intelligently recreates a patient’s breathing pattern so breathing feels more natural. - Touchscreen
Responsive and easy-to-use touchscreen makes navigating settings simple and intuitive. - Over-the-air updates
Deliver features directly to the device, giving patients and providers access to the latest in PAP technology.
Documents center
References
- Source: Randomized Controlled Trial: The Complex Sleep Apnea Resolution Study: CPAP vs. ASV, Morgenthaler, T. et al, 2014.
- Source: Resmed survey of clinicians and new and experienced patients who were asked to set up the AirSense 11 device. AirSense 11 is part of the Air11 platform. Survey conducted in Australia, August 17, 2020 – August 21, 2020. n=23.
* ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnea.
† The myAir by Resmed app is available in English and Spanish in the US and in English and French in Canada.
‡ Coaching entails personalized feedback to encourage continuation of therapy. This is not a healthcare service and is not performed by licensed healthcare providers. Patients are encouraged to speak with their treating clinicians for any clinical symptoms or medical conditions.